Topically Applied Curcumin-Loaded Nanoparticles Treat Erectile Dysfunction in a Rat Model of Type-2 Diabetes

Area of Science:

• Pharmacology
• Nanotechnology
• Urology

Background:

• Erectile dysfunction (ED) in type-2 diabetes (T2D) is a significant health concern.
• Curcumin, an anti-inflammatory agent, shows preclinical promise for ED but suffers from poor oral bioavailability.
• Topical application of curcumin-loaded nanoparticles (curc-np) offers a potential solution to enhance delivery and efficacy.

Purpose of the Study:

• To evaluate the efficacy of topically applied curc-np in treating ED in a T2D rat model.
• To determine if curc-np treatment modulates the expression of inflammatory markers in corporal tissue.
• To assess nanoparticle penetration and curcumin release following topical application.

Main Methods:

• Curcumin-loaded nanoparticles (curc-np) or blank nanoparticles were topically applied to T2D rats over two weeks.
• Erectile function was assessed by measuring intracavernosal pressure (ICP) normalized to systemic blood pressure (ICP/BP).
• Quantitative real-time PCR (RT-qPCR) was used to analyze the expression of various inflammatory and molecular markers in corporal tissue.

Main Results:

• Nanoparticles demonstrated epidermal penetration and persistence in hair follicles for up to 24 hours.
• Curc-np treatment significantly improved ICP/BP compared to blank nanoparticles, particularly at lower stimulation levels (0.75 mA).
• Corporal tissue analysis revealed a 60% decrease in Nkap expression and a 60% increase in heme oxygenase-1 (HO-1) expression in curc-np treated animals.

Conclusions:

• Topical application of curc-np is a viable strategy for delivering curcumin and treating ED in a T2D rat model.
• The treatment modulated key inflammatory pathways, with ICP/BP inversely correlating with Nkap and directly with HO-1 expression.
• Further studies are warranted to optimize protocols and assess toxicity for potential clinical translation in T2D patients with ED.